Adriane Antler has extensive experience in obtaining and evaluating intellectual property protection and in providing strategic counsel to clients. Her practice involves the areas of biotechnology, bioinformatics, and pharmaceuticals.
In addition to the preparation and prosecution of patent applications, a substantial part of Adriane's practice is devoted to the preparation of patentability, infringement, and validity opinions. She performs due diligence evaluations of patent portfolios and provides advice on validity and freedom-to-operate issues in connection with potential investments, licenses, and acquisitions. She has in-depth experience with ex parte reexaminations and inter partes review proceedings. Adriane also participates extensively in opposition proceedings before the European Patent Office and has participated in patent litigations. She has negotiated and prepared contracts involving intellectual property issues such as license, consulting, and sponsored research agreements.
Representative clients include Acorda Therapeutics, Biogen MA Inc., and Memorial Sloan-Kettering Cancer Center.
Since November 2007, Adriane has served as a non-trustee member of the Technology Transfer Committee of the Board of Trustees of The Rockefeller University. She is a member of the American Bar Association, the New York State Bar Association, and the New York Intellectual Property Law Association.
- December 2-6, 2012
Antibody Patenting: The Written Description Requirement, IBC's 23rd Annual International Antibody Engineering Conference and 10th Annual Antibody Therapeutics Conference
- August 4, 2011
Antibody Patenting: Lessons from the Case Law, Global Patent Trends in Life Sciences seminar
- June 7, 2007
Patentability of Inventions Based on Microarray-Generated Expression Data, 2007 Professional Development Meeting of the Ontario Society for Excellence in Technology Transfer (OnSETT)
- June 12-16, 2004
Careers in Patent Law, 2004 Annual Meeting of the American Society for Biochemistry and Molecular Biology and 8th International Union of Biochemistry and Molecular Biology Conference
- Fordham University (J.D. cum laude 1990; Law Review); The Rockefeller University (Ph.D. in Molecular Biology 1986); Yale University (B.S. in Molecular Biophysics and Biochemistry summa cum laude 1980; Phi Beta Kappa)
- New York, District of Columbia, and registered to practice before the United States Patent and Trademark Office
IAM Patent 1000 — The World's Leading Patent Practitioners (2013-2020) published by Intellectual Asset Management magazine
"Life Sciences Star" (2012-2017, 2020), LMG Life Sciences guide of leading firms and attorneys in U.S. life sciences
"IP Stars," Managing Intellectual Property (2013-2020/21)
Recommended by The Legal 500 for patent prosecution (2014-2018)